Analysis of intestinal bacterial flora in adjuvant chemotherapy combined with oxaliplatin for stage III curatively resected colorectal cancer

Analysis of intestinal bacterial flora in adjuvant chemotherapy combined with oxaliplatin for stage III curatively resected colorectal cancer - Analysis of intestinal bacterial flora in adjuvant chemotherapy combined with oxaliplatin for stage III curatively resected colorectal cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038569

Enrollment

Registered

2019-12-01

Start date

2019-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A case of colon cancer histopathologically diagnosed as Stage III

Exclusion criteria

Exclusion criteria: Patients under 20 years old

Design outcomes

Primary

Measure	Time frame
Relationship between changes in gut microbiota and side effects of chemotherapy.	—

Countries

Japan

Contacts

Public ContactYusaku Watanabe

Kawasaki Medical School Digestive Surgery

tanakahr@med.kawasaki-m.ac.jp086-462-1111

Outcome results